Simplex Trading’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,673
Closed -$46.3K 10164
2026
Q1
$47.3K Sell
7,673
-12,125
-61% -$101K ﹤0.01% 5939
2025
Q4
$206K Sell
19,798
-3,556
-15% -$35.7K ﹤0.01% 4211
2025
Q3
$209K Buy
+23,354
New +$205K ﹤0.01% 4895
2025
Q1
Sell
-34,730
Closed -$1.03M 9510
2024
Q4
$1.19M Buy
+34,730
New +$1.57M ﹤0.01% 2665
2024
Q2
Sell
-1,582
Closed -$90.4K 9666
2024
Q1
$81K Sell
1,582
-4,503
-74% -$221K ﹤0.01% 5801
2023
Q4
$245K Buy
+6,085
New +$178K ﹤0.01% 4457

Other funds holding RXST

Simplex Trading's RXST Position: Q2 2026 in Review

Simplex Trading sold out of RxSight (RXST) in Q2 2026, closing a stake of 7,673 shares — an estimated $46.3K sold.

Simplex Trading first reported a position in RXST in Q4 2023 and held it in 6 quarters. The position peaked at $1.19M in Q4 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Simplex Trading reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 7,673 RxSight shares in Q2 2026, an estimated $46.3K.
  • Simplex Trading first reported a position in RxSight in Q4 2023 and held it in 6 quarters.
  • Simplex Trading's RxSight position peaked at $1.19M in Q4 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.